Stifel Financial Corp Clovis Oncology, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.85 $1,407 - $3,819	-1,340 Reduced 3.34%	38,781 $46,000
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.96 $7,643 - $35,913	12,133 Added 43.35%	40,121 $72,000
Q1 2022 May 13, 2022	BUY	$1.43 - $3.14 $7,457 - $16,375	5,215 Added 22.9%	27,988 $57,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $12,136 - $21,396	-4,495 Reduced 16.48%	22,773 $62,000
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $6,938 - $9,912	-1,709 Reduced 5.9%	27,268 $122,000
Q2 2021 Aug 13, 2021	BUY	$5.02 - $7.05 $818 - $1,149	163 Added 0.57%	28,977 $168,000
Q1 2021 May 14, 2021	SELL	$4.81 - $10.34 $36,305 - $78,046	-7,548 Reduced 20.76%	28,814 $202,000
Q4 2020 Feb 12, 2021	SELL	$4.13 - $6.41 $7,892 - $12,249	-1,911 Reduced 4.99%	36,362 $175,000
Q3 2020 Nov 16, 2020	SELL	$4.82 - $7.72 $12,613 - $20,203	-2,617 Reduced 6.4%	38,273 $223,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $41,491 - $70,659	7,292 Added 21.7%	40,890 $276,000
Q1 2020 May 14, 2020	BUY	$3.77 - $11.0 $28,203 - $82,291	7,481 Added 28.64%	33,598 $210,000
Q4 2019 Feb 13, 2020	BUY	$3.0 - $16.43 $78,351 - $429,102	26,117 New	26,117 $272,000
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $162,725 - $326,086	-12,703 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $6,816 - $11,688	386 Added 3.13%	12,703 $315,000
Q4 2018 Feb 13, 2019	SELL	$11.63 - $32.67 $71,850 - $201,835	-6,178 Reduced 33.4%	12,317 $219,000
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $209,672 - $353,237	-7,139 Reduced 27.85%	18,495 $537,000
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $283,147 - $420,076	6,732 Added 35.62%	25,634 $1.17 Million
Q1 2018 May 11, 2018	BUY	$50.12 - $67.72 $148,054 - $200,044	2,954 Added 18.52%	18,902 $997,000
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $58,843 - $86,271	1,020 Added 6.83%	15,948 $1.09 Million
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $1 Million - $1.27 Million	14,928	14,928 $0

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account